260 related articles for article (PubMed ID: 26123760)
1. P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility.
Hou J; Gu Y; Hou W; Wu S; Lou Y; Yang W; Zhu L; Hu Y; Sun M; Xue H
BMC Genet; 2015 Jun; 16():72. PubMed ID: 26123760
[TBL] [Abstract][Full Text] [Related]
2. p53 Arg72Pro polymorphism, HPV status and initiation, progression, and development of cervical cancer: a systematic review and meta-analysis.
Habbous S; Pang V; Eng L; Xu W; Kurtz G; Liu FF; Mackay H; Amir E; Liu G
Clin Cancer Res; 2012 Dec; 18(23):6407-15. PubMed ID: 23065429
[TBL] [Abstract][Full Text] [Related]
3. Association between p53 Arg72Pro polymorphism and the risk of human papillomavirus-related head and neck squamous cell carcinoma: a meta-analysis.
Xia LY; Zeng XT; Li C; Leng WD; Fan MW
Asian Pac J Cancer Prev; 2013; 14(10):6127-30. PubMed ID: 24289637
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India.
Nagpal JK; Patnaik S; Das BR
Int J Cancer; 2002 Feb; 97(5):649-53. PubMed ID: 11807792
[TBL] [Abstract][Full Text] [Related]
5. p53 Codon 72 polymorphism in oral exfoliated cells in a Sudanese population.
Sand L; Jalouli MM; Jalouli J; Sapkota D; Ibrahim SO
In Vivo; 2012; 26(1):59-62. PubMed ID: 22210716
[TBL] [Abstract][Full Text] [Related]
6. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.
Ji X; Neumann AS; Sturgis EM; Adler-Storthz K; Dahlstrom KR; Schiller JT; Wei Q; Li G
Carcinogenesis; 2008 Apr; 29(4):875-9. PubMed ID: 18258602
[TBL] [Abstract][Full Text] [Related]
7. p53 codon 72 polymorphism and hematological cancer risk: an update meta-analysis.
Weng Y; Lu L; Yuan G; Guo J; Zhang Z; Xie X; Chen G; Zhang J
PLoS One; 2012; 7(9):e45820. PubMed ID: 23029260
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between p53 Arg72Pro polymorphism and cervical carcinoma in Uigur and Han women in Xinjiang].
Zheng XZ; Yang AQ; Pan XL; Zheng LL; Zhou QY; Li XM; Wang XL; Yan LH; Li HA
Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):511-5. PubMed ID: 17980096
[TBL] [Abstract][Full Text] [Related]
9. Association between p53 Arg72Pro polymorphism and thyroid cancer risk: a meta-analysis.
Wu B; Guo D; Guo Y
Tumour Biol; 2014 Jan; 35(1):561-5. PubMed ID: 24037912
[TBL] [Abstract][Full Text] [Related]
10. P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation.
Makni H; Franco EL; Kaiano J; Villa LL; Labrecque S; Dudley R; Storey A; Matlashewski G
Int J Cancer; 2000 Aug; 87(4):528-33. PubMed ID: 10918193
[TBL] [Abstract][Full Text] [Related]
11. No significant association between p53 codon 72 Arg/Pro polymorphism and risk of oral cancer.
Jiang N; Pan J; Wang L; Duan YZ
Tumour Biol; 2013 Feb; 34(1):587-96. PubMed ID: 23192640
[TBL] [Abstract][Full Text] [Related]
12. p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer.
Summersgill KF; Smith EM; Kirchner HL; Haugen TH; Turek LP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Sep; 90(3):334-9. PubMed ID: 10982955
[TBL] [Abstract][Full Text] [Related]
13. P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype.
Rogler A; Rogenhofer M; Borchardt A; Lunz JC; Knoell A; Hofstaedter F; Tannapfel A; Wieland W; Hartmann A; Stoehr R
Pathobiology; 2011; 78(4):193-200. PubMed ID: 21778786
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India.
Katiyar S; Thelma BK; Murthy NS; Hedau S; Jain N; Gopalkrishna V; Husain SA; Das BC
Mol Cell Biochem; 2003 Oct; 252(1-2):117-24. PubMed ID: 14577584
[TBL] [Abstract][Full Text] [Related]
15. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer.
Madeleine MM; Shera K; Schwartz SM; Daling JR; Galloway DA; Wipf GC; Carter JJ; McKnight B; McDougall JK
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):225-7. PubMed ID: 10698487
[TBL] [Abstract][Full Text] [Related]
16. p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort.
Pantelis A; Pantelis D; Ruemmele P; Hartmann A; Hofstaedter F; Buettner R; Bootz F; Stoehr R
Oncol Rep; 2007 May; 17(5):1243-8. PubMed ID: 17390072
[TBL] [Abstract][Full Text] [Related]
17. Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients.
Michopoulou V; Derdas SP; Symvoulakis E; Mourmouras N; Nomikos A; Delakas D; Sourvinos G; Spandidos DA
Tumour Biol; 2014 Dec; 35(12):12765-73. PubMed ID: 25213701
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the codon 72 polymorphism of TP53 and human papillomavirus infection in Iranian patients with prostate cancer.
Salehi Z; Hadavi M
J Med Virol; 2012 Sep; 84(9):1423-7. PubMed ID: 22825821
[TBL] [Abstract][Full Text] [Related]
19. No Evidence of Association of the Arg72Pro p53 Gene Polymorphism with Cancer Risk in the Saudi Population: a Meta-Analysis.
Irshad M; Mandal RK; Al-Drees A; Khalil MS; Abdulghani HM
Asian Pac J Cancer Prev; 2015; 16(14):5663-7. PubMed ID: 26320432
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of associations between the TP53 Arg72Pro polymorphism with risk of head and neck carcinomas based on case-control studies.
Ren WH; Jiang DK; Pei Y; Wang SQ; Yang XM; Yu L
Genet Mol Res; 2014 Jan; 13(1):103-14. PubMed ID: 24446292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
